QuidelOrtho plans to sell testing unit for $1.5B: FT
Seeking Alpha ·
QuidelOrtho ( QDEL ) is looking to sell its point-of-care testing unit at a $1.5B valuation, and private equity groups have already expressed interest in the transaction, The Financial Times reported on Saturday, citing people familiar with the matter.
DYAX Investor Sentiment
Bullish (Long) 54% · Bearish (Short) 46%
271 participants
Related News
- Notable analyst calls this week: Nike, Qualcomm and Super Micro among top picks
- Insurers in gainers; Goldman Sachs, Morgan Stanley among losers: week's financials wrap
- Bahrain faces drone attack; tanker hit in the Strait of Hormuz, risking U.S.-Iran truce
- Here's Exactly How We Fixed Social Security the Last Time It Was Running Out of Money
- Stock Market Week Ahead: Rotating, For Now, Away From The AI Boom
- What a Kevin Warsh-Led Fed Could Mean for Mortgage REITs AGNC and Annaly Capital